Option chain shows key data for Maple Gold Mines's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Maple Gold Mines.

Maple Gold Mines (OTC:MGMLF) Stock, Option Chain

Maple Gold Mines Ltd is a Canadian advanced exploration company in a 50/50 joint venture with Agnico Eagle Mines Ltd to jointly advance the district-scale Douay and Joutel gold projects located in Quebec's prolific Abitibi Greenstone Gold Belt. The district-scale property package also hosts a significant number of regional exploration targets along a 55 km strike length of the Casa Berardi Deformation Zone that have yet to be tested through drilling, making the project ripe for new gold and polymetallic discoveries. Its segment includes mineral exploration in Canada. The company is well-capitalized and is currently focused on carrying out exploration and drill programs to grow resources and make new discoveries to establish an exciting new gold district in the heart of the Abitibi.

Earnings

Earnings Beats

News

Penny Stocks

Markets

Analyst Ratings

Trading Ideas

MGMLF

Agnico Eagle Mines Limited (NYSE: AEM) acquired 33,821,842 Maple Gold Mines Ltd. (OTC: MGMLF) common shares for 8.5 cents per share, totaling approximately C$2.87 million.

Agnico Eagle Bumps Up Stake in Maple Gold Mines to 19.9%

Commodities

Management

Exclusives

Interview

$BTC

TSXV:MGM

Spot gold was trading near the $1,930 mark on Wednesday in continued consolidation after a four-month sprint brought the commodity up 20% from the Sept. 28 low of $1,614.92.

EXCLUSIVE: Maple Gold Mines CEO On The Gold Outlook, Bitcoin And What&#39;s Next For The Miner In 2023

Intraday Update

Movers

ABEV

AFFINITY BEVERAGE GROUP by Affinity Beverage Group, Inc.

ABVG

ACST

AMRB

ANGO

APYP

AROC

AWCMY

BIOIF

BLPH

BNFT

BORR

CASI

CURATIVE BIOSCIENCES INC by Curative Biosciences, Inc.

CBDX

CBDY

CDEV

CEQP

CGOTF

CHMG

CNXS

COVTY

CVGW

DNOW

DRRSF

ECAOF

ECMXF

ECOL

EEVVF

EJPRY

EOLS

ETRN

EXTN

FANG

FARYF

FNKO

FRLF

GALT

GGBXF

GGLT

GGTTF

GIGNF

GLBS

GLNG

GMLP

GPOR

HEXO

HNRG

HRCXF

HUSKF

JMEI

JMPLF

KAYS

KELYA

KEQU

KKPNY

KRKR

LIFZF

LQDT

MBRX

MFCSF

MICWF

MPLX

MRNJ

MRQRF

MTRX

MTSC

MZDAY

NEPT

NINOY

NSANY

NSPDF

NTGR

Stocks That Hit 52-Week Lows On Monday

MAPLE GOLD MINES LTD by Maple Gold Mines Ltd.

Maple Gold Mines Ltd

DOMH

Dominari  Shares Resume Trade

Canaccord Genuity analyst Edward Nash downgrades Pliant Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) from Buy to Hold and announces $4 price target.

Downgrades

Price Target

PLRX

Canaccord Genuity Downgrades Pliant Therapeutics to Hold, Announces $4 Price Target

Susquehanna analyst Shyam Patil maintains Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) with a Neutral and raises the price target from $90 to $110.

FTNT

Susquehanna Maintains Neutral on Fortinet, Raises Price Target to $110

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/02/2025-02-10_08h28_44.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">New Tariffs</h4>
Please <a href="https://thearorareport.com/chart-analysis-stock-market-china-gold-steel-tariffs-nue-mc-02102025">click here</a> for a chart of Nucor Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>).
Note the following:
<ul>
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of NUE is being used to illustrate the point.</li>
<li>NUE is the biggest steel maker in the U.S.</li>
<li>The chart shows when the stock started falling on weakening steel demand.</li>
<li>The chart shows when earnings were reported.&nbsp; NUE guided earnings below consensus.</li>
<li>The chart shows the stock has been rising in anticipation of Trump imposing tariffs.</li>
<li>The chart shows that the stock is gapping up this morning on Trump imposing 25% tariffs on all steel and aluminum from all countries.</li>
<li>Trump is also threatening that he will impose reciprocal tariffs this week. The threat of reciprocal tariffs, in The Arora Report analysis, will be a much bigger deal.</li>
<li>What a difference a week makes. Last Monday, the stock market opened down significantly when Trump had not removed the tariffs on Canada and Mexico.  Today, on Trump imposing tariffs on steel and aluminum, the momo crowd is aggressively buying stocks.  </li>
<li>In The Arora Report analysis, Trump is not likely to quickly back off from the tariffs on steel and aluminum like he previously did with Canada and Mexico.&nbsp;&nbsp;</li>
<li>At one time, China was the biggest exporter of steel and aluminum to the U.S.&nbsp; Now, Canada is the biggest exporter of steel and aluminum to the U.S. Canada produces a lot of steel and aluminum but it also gets a lot of steel and aluminum from China.</li>
<li>China has freed up billions of dollars to buy gold.&nbsp; Please see the gold section below.</li>
<li>In The Arora Report analysis, prudent investors need to make a special note of momo crowd behavior.&nbsp; The momo crowd is now buying stocks on Trump imposing tariffs.&nbsp; Yet, tariffs pose a risk.&nbsp; As such, logic would dictate trimming stocks, not buying stocks, on the imposition of tariffs.&nbsp; In The Arora Report analysis, part of the momo crowd's actions are the result of Trump's rising popularity.&nbsp; A CBS poll shows Trump's approval rating is at a new high.</li>
<li>Sentiment remains in the extreme positive zone.  The momo crowd buying last week was the most aggressive since late 2021.  You may recall a bear market ensued in 2022 when Nasdaq lost 33%.  As a reminder, sentiment is a contrary indicator.  In plain English, extreme positive sentiment is a sell signal.  However, as we have previously shared, sentiment is not a precise timing signal.  Investors should use a 360 degree analysis, such as the adaptive ZYX Asset Allocation Model with inputs in ten categories.</li>
<li>This is a big week for inflation data.&nbsp; Consumer Price Index (CPI) will be released on Wednesday at 8:30am ET.&nbsp; Producer Price Index (PPI) will be released on Thursday at 8:30am ET.</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in Apple Inc (AAPL), Amazon.com, Inc. (AMZN), Alphabet Inc Class C(GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), and NVIDIA Corp (NVDA).
In the early trade, money flows are negative in Tesla Inc (TSLA).
In the early trade, money flows are positive in SPDR S&amp;P 500 ETF Trust (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is range bound.
<h4 class="wp-block-heading">Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.&nbsp; The proprietary protection band from The Arora Report is very popular.&nbsp; The protection band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Equities

Momo Crowd Buys Stocks On Trump Imposing New Tariffs, China Frees Up Billions To Buy Gold

Susquehanna analyst James Friedman maintains Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) with a Positive and raises the price target from $230 to $270.

Susquehanna Maintains Positive on Fiserv, Raises Price Target to $270

WIIM

Bristol-Myers Squibb shares are trading lower. The company announced Phase 2 TRANSCEND FL trial evaluating Breyanzi in adult patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma.

On Monday,&nbsp;Incyte&nbsp;Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) reported&nbsp;fourth-quarter revenue&nbsp;of $1.18 billion, up 16% year over year and beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $1.14 billion</a>.
The company reported an adjusted EPS of $1.43, which was up from $1.06 a year ago and missing the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43588372/incyte-reports-2024-fourth-quarter-and-year-end-financial-results-provides-2025-financial-guidance" rel="noreferrer noopener">consensus estimate of $1.56</a>.
Jakafi&#8217;s net product revenue increased 11% to $773.1 million, primarily due to a 14% increase in paid demand.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42974065/incyte-at-jpm25-eyes-transformational-2025-with-multiple-drug-launches-and-expanding-pipeline" rel="noreferrer noopener">Incyte At JPM25: Eyes Transformational 2025 With Multiple Drug Launches And Expanding Pipeline</a>
Opzelura net product revenue increased 48% to $161.6 million, driven by continued growth in new patient starts and refills in the U.S. and increased contribution from Europe.
Minjuvi/Monjuvi net product revenue increased 265% to $32.81 million, as the company recognized all revenue from sales of Monjuvi in the United States following the acquisition of exclusive global rights for tafasitamab in February 2024.
&#8220;2024 was an important year for Incyte, with a 15% increase in total revenues, driven by strong growth from both Jakafi and Opzelura, as well as significant progress across our R&amp;D pipeline,&#8221; said Hervé Hoppenot, Chief Executive Officer, Incyte.
Guidance: Incyte forecasts 2025 Jakafi revenue of $2.925 billion-$2.975 billion, up 4.76%-6.55% from 2024.
Opzelura sales are expected to increase between 23.9%-31.81% to $630 million-$670 million.
&#8220;Looking ahead to 2025, we anticipate a year of continued strong revenue growth and diversification, as well as several defining milestones that will serve as an inflection point for Incyte. A year ago, we set the goal to achieve more than 10 impactful product launches by 2030. In 2025, a number of key catalysts across the entire portfolio will bring that goal closer to reality,&#8221; Hoppenot added.
Incyte says 2025 is expected to be a year of defining catalysts with four launches, four pivotal study readouts, at least three Phase 3 study initiations, and seven proof-of-concept study readouts.
William Blair writes, &#8220;We continue to see steady growth of Jakafi in approved indications and believe that ongoing studies for lifecycle management could provide upside to current peak sales and offer the potential to extend Jakafi franchise exclusivity. We believe that Opzelura should provide Incyte with an additional meaningful commercial opportunity in large immune dermatological indications. Povorcitinib remains underappreciated by investors and has the potential to be a major value driver by the end of this decade.&#8221;
The analyst Matt Phipps reiterates <a target="_blank" href="https://www.benzinga.com/quote/INCY/analyst-ratings" rel="noreferrer noopener">the Outperform rating</a>.
In November, Incyte&nbsp;announced that it would pause enrollment in the ongoing Phase 2 study of MRGPRX2 (INCB000262) in chronic&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/42069374/incytes-750-million-escient-deal-faces-setback-with-toxicology-issues-in-two-investigational-drugs-analyst-flags-challenges" rel="noreferrer noopener">spontaneous urticaria (CSU)</a>.
The decision was made following the observation of certain in vivo preclinical toxicology findings.
Price Action:&nbsp;INCY stock is down 6.79% at $69.10 at the last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43570221/analysts-see-positive-momentum-for-expedia-on-strong-q4-earnings" target="_blank" rel="noreferrer noopener">Expedia&#8217;s Travel Momentum Grows, But Analysts Await Clearer Signs Of Long-Term Upside</a></li>
</ul>

Analyst Color

Biotech

Guidance

Health Care

General

INCY

Incyte Q4 Earnings: EPS Miss, Strong Jakafi And Opzelura Sales, Says 2025 To Be Catalyst Rich Including 4 Launches

Susquehanna analyst Shyam Patil maintains Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) with a Neutral and raises the price target from $190 to $205.

EXPE

Susquehanna Maintains Neutral on Expedia Group, Raises Price Target to $205

Dominari Shares Halted On Circuit Breaker To The Upside, Stock Now Up 60.9%

Lyft Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) shares are trading higher Monday following a report indicating the company could launch robotaxis <a href="https://www.benzinga.com/pressreleases/25/01/b43113669/lyft-to-announce-fourth-quarter-and-full-year-2024-financial-results">as soon as 2026</a>. 
What To Know: Lyft is planning to bring a fully autonomous robotaxi service to its app in collaboration with Mobileye Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) as soon as 2026, according to <a href="https://techcrunch.com/2025/02/10/lyft-to-launch-mobileye-powered-robotaxis-as-soon-as-2026-starting-with-dallas/">TechCrunch</a>.
The company plans to test the service in Dallas to start with more markets expected to follow. 
Japanese conglomerate Marubeni will reportedly own and finance the Mobileye-equipped vehicles set to become available for rides on Lyft&#8217;s mobile app. Lyft has not disclosed an OEM partner for the launch or said how many vehicles will be launched in Dallas for the initial rollout. 
The news comes a day ahead of Lyft&#8217;s fourth-quarter financial results. Analysts expect the company to report earnings of 22 cents per share and revenue of $1.56 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43314361/lyft-faces-growing-competition-bank-of-america-analyst-warns#google_vignette">Lyft Faces Growing Competition, Bank of America Analyst Warns</a>
Last quarter, Lyft shares surged after the company reported better-than-expected financial results as gross booking grew 16% year-over-year and active riders and rides reached new all-time highs. 
&#8220;Going forward, our work with best-of-breed partners and the autonomous future we&#8217;re building will give people even more reasons to choose Lyft every time,&#8221; CEO David Risher said at the time.
Lyft guided for full-year 2024 rides growth in the mid-teens on a year-over-year basis, and fourth-quarter gross bookings up 15% to 17%. Adjusted EBITDA is expected to be between $100 million and $105 million in the fourth quarter and full-year free cash flow is expected to exceed $650 million.
LYFT Price Action: <a href="http://benzinga.com/lyft">Lyft shares</a> were up 4.48% at $14.81 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

LYFT

MBLY

Lyft Stock Is Moving Higher Monday: Here's Why

BABA

Alibaba shares are trading higher after President Trump reportedly postponed tariffs on packages under $800 from China.

Scotiabank analyst Jonathan Goldman maintains WSP Global (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WSP#TSX">WSP</a>) with a Sector Outperform and raises the price target from C$279 to C$281.

TSX:WSP

Scotiabank Maintains Sector Outperform on WSP Global, Raises Price Target to C$281

GRCE

Grace Therapeutics shares are trading higher after the company announced its Phase 3 STRIVE-ON safety trial of GTx-104 in aSAH met its primary endpoint. Additionally, the company announced a $30 million private placement.

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 10th:
The Greenbrier Companies GBX: This leading supplier of transportation equipment and services to the railroad and related industries carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.5% over the last 60 days.
<div class="chart_embed">
<h3>Greenbrier Companies, Inc. (The) Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/GBX/price-consensus-chart?icid=chart-GBX-price-consensus-chart"><img alt="Greenbrier Companies, Inc. (The) Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/ac/1739177989.png" style="height:264px; width:568px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/GBX/price-consensus-chart?icid=chart-GBX-price-consensus-chart">Greenbrier Companies, Inc. (The) price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/GBX?icid=chart-GBX-price-consensus-chart">Greenbrier Companies, Inc. (The) Quote</a>
</div>
Greenbrier has a PEG ratio of 0.94 compared with 1.97 for the industry. The company possesses a <a href="https://www.zacks.com/style-scores-education/">Growth Score</a>&nbsp; of A.
<div class="chart_embed">
<h3>Greenbrier Companies, Inc. (The) PEG Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/GBX/fundamental/peg-ratio-ttm?icid=chart-GBX-fundamental/peg-ratio-ttm">TTM</a>)&quot; height=&quot;250&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/31/1739178886.png&quot; title=&quot;&quot; width=&quot;527&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/GBX/fundamental/peg-ratio-ttm?icid=chart-GBX-fundamental/peg-ratio-ttm">Greenbrier Companies, Inc. (The) peg-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/GBX?icid=chart-GBX-fundamental/peg-ratio-ttm">Greenbrier Companies, Inc. (The) Quote</a>
</div>
Pilgrim&#39;s Pride Corporation PPC: This producer of fresh and frozen meat products carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 2% over the last 60 days.
<div class="chart_embed">
<h3>Pilgrim&#39;s Pride Corporation Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/PPC/price-consensus-chart?icid=chart-PPC-price-consensus-chart"><img alt="Pilgrim's Pride Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/5c/1739178000.png" style="height:264px; width:568px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/PPC/price-consensus-chart?icid=chart-PPC-price-consensus-chart">Pilgrim&#39;s Pride Corporation price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/PPC?icid=chart-PPC-price-consensus-chart">Pilgrim&#39;s Pride Corporation Quote</a>
</div>
Pilgrim&#39;s Pride has a PEG ratio of 0.21 compared with 0.58 for the industry. The company possesses a Growth Score of A.
<div class="chart_embed">
<h3>Pilgrim&#39;s Pride Corporation PEG Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/PPC/fundamental/peg-ratio-ttm?icid=chart-PPC-fundamental/peg-ratio-ttm">TTM</a>)&quot; height=&quot;250&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/d4/1739178899.png&quot; title=&quot;&quot; width=&quot;527&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/PPC/fundamental/peg-ratio-ttm?icid=chart-PPC-fundamental/peg-ratio-ttm">Pilgrim&#39;s Pride Corporation peg-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/PPC?icid=chart-PPC-fundamental/peg-ratio-ttm">Pilgrim&#39;s Pride Corporation Quote</a>
</div>
Pitney Bowes Inc. PBI: This company that&nbsp;provides SaaS shipping solutions, mailing innovation, and financial services carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.
<div class="chart_embed">
<h3>Pitney Bowes Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/PBI/price-consensus-chart?icid=chart-PBI-price-consensus-chart"><img alt="Pitney Bowes Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/d2/1739178025.png" style="height:264px; width:562px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/PBI/price-consensus-chart?icid=chart-PBI-price-consensus-chart">Pitney Bowes Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/PBI?icid=chart-PBI-price-consensus-chart">Pitney Bowes Inc. Quote</a>
</div>
Pitney Bowes has a PEG ratio of 0.51 compared with 3.05 for the industry. The company possesses a Growth Score of A.
<div class="chart_embed">
<h3>Pitney Bowes Inc. PEG Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/PBI/fundamental/peg-ratio-ttm?icid=chart-PBI-fundamental/peg-ratio-ttm">TTM</a>)&quot; height=&quot;250&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/82/1739178993.png&quot; title=&quot;&quot; width=&quot;527&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/PBI/fundamental/peg-ratio-ttm?icid=chart-PBI-fundamental/peg-ratio-ttm">Pitney Bowes Inc. peg-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/PBI?icid=chart-PBI-fundamental/peg-ratio-ttm">Pitney Bowes Inc. Quote</a>
</div>
&nbsp;
See the <a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link&amp;ICID=zpi%20_1link">full list of top ranked stocks here.</a>
&nbsp;
Learn more about the <a href="https://www.zacks.com/education/stock-scorecard/growth-trading">Growth score and how it is calculated here.</a>
&nbsp;
<h2>Just Released: Zacks Top 10 Stocks for 2025</h2>
Hurry &ndash; you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&amp;P 500&#39;s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. 
&nbsp;
<a href="https://www.zacks.com/registration/top10/welcome/eoffer/5283?adid=SYND_BENZ_ZU_TOP10POST_ZACKS1RANKADDITIONS_269_02102025_2412410&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410" style="font-weight:bold">See New Top 10 Stocks &gt;&gt;</a>
&nbsp;
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BST_LP194&amp;ADID=SYND_BENZ_7BEST_ZACKS1RANKADDITIONS_269_2412410&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410" target="_blank">Click to get this free report</a>

&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=PBI&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_269_2412410_PBI&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410">Pitney Bowes Inc. (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/pbi#NYSE">PBI</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=PPC&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_269_2412410_PPC&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410">Pilgrim&#39;s Pride Corporation (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/ppc#NYSE">PPC</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=GBX&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_269_2412410_GBX&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410">Greenbrier Companies, Inc. (The) (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/gbx#NYSE">GBX</a>): Free Stock Analysis Report
<a href="https://www.zacks.com/commentary/2412410/best-growth-stocks-to-buy-for-february-10th?cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410">To read this article on Zacks.com click here.</a>
<a href="https://www.zacks.com/">Zacks Investment Research</a>

Small Cap

Best Growth Stocks To Buy For February 10th

Essential Props Realty's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPRT#NYSE">EPRT</a>) short percent of float has fallen 4.58% since its last report. The company recently reported that it has 11.69 million shares sold short, which is 9.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.37 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Essential Props Realty Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739201423_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Essential Props Realty has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Essential Props Realty's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Essential Props Realty's peer group average for short interest as a percentage of float is 2.39%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

EPRT

Peering Into Essential Props Realty's Recent Short Interest

EMCOR Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) short percent of float has risen 41.73% since its last report. The company recently reported that it has 695 thousand shares sold short, which is 1.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.8 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>EMCOR Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739201417_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for EMCOR Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing EMCOR Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, EMCOR Group's peer group average for short interest as a percentage of float is 5.62%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(EME) - Analyzing EMCOR Group's Short Interest

F5's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NYSE">FFIV</a>) short percent of float has risen 4.28% since its last report. The company recently reported that it has 1.63 million shares sold short, which is 3.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.38 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>F5 Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739201412_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for F5 has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing F5's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, F5's peer group average for short interest as a percentage of float is 6.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

FFIV

Peering Into F5's Recent Short Interest

AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) has outperformed the market over the past 10 years by 3.29% on an annualized basis producing an average annual return of 14.42%. Currently, AECOM has a market capitalization of $14.25 billion. 
Buying $100 In ACM: If an investor had bought $100 of ACM stock 10 years ago, it would be worth $384.51 today based on a price of $107.39 for ACM at the time of writing.
<h3>AECOM's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739201409_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

CORRECTION :JMP Securities analyst Matthew Carletti reiterates Skyward Specialty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKWD#NASDAQ">SKWD</a>) with a Market Outperform and raises the price target from $53 to $60.((Change in price target from from $53 to $60)

Reiteration

SKWD

CORRECTION : JMP Securities Reiterates Market Outperform on Skyward Specialty, Raises Price Target to $60 (Change in price target from from $53 to $60)

Scotiabank analyst Patrick Colville maintains SolarWinds (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWI#NYSE">SWI</a>) with a Sector Perform and raises the price target from $15 to $18.5.

Scotiabank Maintains Sector Perform on SolarWinds, Raises Price Target to $18.5

Press Releases

Maple Gold Announces Joint Venture Restructuring Transaction with Agnico Eagle and C$4.05 Million Flow-Through Private Placement

Maple Gold Announces Closing of C$4.05 Million Flow-Through Private Placement

Maple Gold Strengthens Board and Management Team with Addition of Seasoned Mining Executives

Maple Gold Announces Closing of $5 Million Brokered Private Placement

Maple Gold Announces Final Closing of Brokered Private Placement for Total Proceeds of $5.6 Million

Maple Gold Appoints New Chief Financial Officer to Management Team

Maple Gold Completes Joint Venture Restructuring Transaction

Maple Gold Commences 10,000 Metre Phase I Drill Program at Douay and Provides 2025 Outlook for the Douay/Joutel Gold Project

Maple Gold Mines

Comments

Maple Gold Mines

Maple Gold Mines (MGMLF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga